Where does Parenteral Technologies, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Parenteral Technologies, LLC ranks #24,975 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Parenteral Technologies, LLC hold?

Parenteral Technologies, LLC holds 11 US utility patents granted between 2015 and 2022, spanning 3 technology areas.

What is Parenteral Technologies, LLC's Innovation Score?

Parenteral Technologies, LLC has an Innovation Score of 29.0 out of 100 (29th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Parenteral Technologies, LLC's patent grant rate increasing or decreasing?

Parenteral Technologies, LLC's recent grant velocity is -17% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Parenteral Technologies, LLC's patents?

Parenteral Technologies, LLC's patents average 16.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Parenteral Technologies, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Parenteral Technologies, LLC

Q: What technology areas does Parenteral Technologies, LLC focus on?

Parenteral Technologies, LLC's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 10 patents, ranking #701 of 3,490 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 3 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Parenteral ranks #24,975 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 3 technology areas.

#24,975
of 49,997 US assignees by volume: 29th percentile
by Innovation Score (29.0/100): 16.4
avg claims per patent: -17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24975 · US Corporation #24,975 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,975/49,997
PHOTO-FINISH Packaging & Inspection
CPC-NARROW A61M · 3 areas
INNOV-THIN 29.0/100
CLAIMS-RICH 16.4 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Packaging Technologies & Inspection, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Parenteral’s 29.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (30%) Velocity 4.4 pts (15%) Breadth 6.1 pts (21%) Claim depth 9.8 pts (34%)

Qualcomm Incorporated · highest

85
Parenteral · this assignee

29
3D Lighting… · lowest

7

What this shows Parenteral's Innovation Score is 29.0/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Parenteral?

Each dot is one of Parenteral’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Parenteral’s own 16.4 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Parenteral vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Parenteral's grants concentrate

Parenteral Technologies, LLC is a focused PatentsView assignee: 3 CPC subclasses with 90.9% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2015. By volume, Parenteral sits between Packaging Technologies & Inspection, LLC and PeptiDream Inc..

Parenteral's three-year grant acceleration

Parenteral Technologies, LLC shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Packaging & Inspe…

11
Pandion Operations

11
Paper-pak Industr…

11
Paradigm Health a…

11
Parker Hannifin M…

11
Pattern Bioscience

11
Pendotech

11
Peptidream

11
Parenteral ◀

11

What this shows Parenteral holds 11 patents at rank #24,987, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Parenteral

By rank, the assignees closest to #24,987 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Parenteral's primary technology class.

Parenteral's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 29th percentile higher than 29% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Parenteral Technologies, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	9.1%
2016	2	18.2%
2017	2	18.2%
2018	1	9.1%
2020	2	18.2%
2021	1	9.1%
2022	2	18.2%

Which technologies does Parenteral Technologies, LLC patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 10

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 4

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Parenteral Technologies, LLC's patent record in context - here's where to go next.

Parenteral Technologies, LLC's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 90.9% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #24,975 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Parenteral Technologies, LLC against Packaging Technologies & Inspection, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.